IP Library Granted Patent US 7,488,815
Granted Patent B2
US 7,488,815 · App. 11/084,085 · Granted Feb 10, 2009

Gene imprinting and methylated CpG islands

Assignee: The Johns Hopkins University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,488,815
App. No.
11/084,085
Granted
Feb 10, 2009
Kind
B2
Abstract

Genomic imprinting is a parent of origin-dependent gene silencing that involves marking of alleles in the germline and differential expression in somatic cells of the offspring. Imprinted genes and abnormal imprinting have been implicated in development, human disease, and embryonic stem cell transplantation. We have established a model system for genomic imprinting using pluripotent 8.5 d.p.c. mouse embryonic germ (EG) cell lines derived from an interspecific cross. We find that allele-specific imprinted gene expression has been lost in these cells. However, partial restoration of allele-specific silencing can occur for some imprinted genes after in vitro differentiation of EG cells into somatic cell lineages, indicating the presence of a gametic memory that is separable from allele-specific gene silencing. We have also generated a library containing most methylated CpG islands. A subset of these clones was analyzed and revealed a subdivision of methylated CpG islands into 4 distinct subtypes: CpG islands belonging to high copy number repeat families; unique CpG islands methylated in all tissues; unique methylated CpG islands that are unmethylated in the paternal germline; and unique CpG islands methylated in tumors. This approach identifies a methylome of methylated CpG islands throughout the genome.

Claims (3)

1. An isolated and purified CpG island, wherein the CpG island comprises the nucleic acid sequence as set forth in SEQ ID NO:56.

2. The CpG island of claim 1 , wherein the CpG island is methylated.

3. The CpG island of claim 1 , wherein the CpG island is unmethylated.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 21, 2019
From: THE JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 049550/0458 →
Continuity (4)
Continuation 0986189300 · May 22, 2001
Provisional Application 6020616100 · May 22, 2000
Provisional Application 6020615800 · May 22, 2000
Related Publication 20050282147A1 · Dec 22, 2005